201
Views
6
CrossRef citations to date
0
Altmetric
Review

Parkinson’s disease management and impulse control disorders: current state and future perspectives

, , , , , , ORCID Icon & show all
Pages 495-508 | Received 06 Dec 2018, Accepted 15 May 2019, Published online: 31 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Isabella Berardelli, Daniele Belvisi, Massimo Pasquini, Andrea Fabbrini, Federica Petrini & Giovanni Fabbrini. (2019) Treatment of psychiatric disturbances in hypokinetic movement disorders. Expert Review of Neurotherapeutics 19:10, pages 965-981.
Read now

Articles from other publishers (5)

J. Koschel, K. Ray Chaudhuri, L. Tönges, M. Thiel, V. Raeder & W. H. Jost. (2021) Implications of dopaminergic medication withdrawal in Parkinson’s disease. Journal of Neural Transmission 129:9, pages 1169-1178.
Crossref
Giorgio Conta, Alberto Libanori, Trinny Tat, Guorui Chen & Jun Chen. (2021) Triboelectric Nanogenerators for Therapeutic Electrical Stimulation. Advanced Materials 33:26, pages 2007502.
Crossref
Sanskriti Sasikumar, Roberto Matta, Renato P. Munhoz, Mateusz Zurowski, Yu‐Yan Poon, Mojgan Hodaie, Suneil K. Kalia, Andres M. Lozano & Alfonso Fasano. (2021) Advanced Therapies for the Management of Dopamine Dysregulation Syndrome in Parkinson's Disease. Movement Disorders Clinical Practice 8:3, pages 400-405.
Crossref
Marina Picillo, Onanong Phokaewvarangkul, Yu‐Yan Poon, Cameron C. McIntyre, Sinem Balta Beylergil, Renato P. Munhoz, Suneil K. Kalia, Mojgan Hodaie, Andres M. Lozano & Alfonso Fasano. (2020) Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease. Movement Disorders 36:3, pages 672-680.
Crossref
Amanda Cano, Elena Sánchez-López, Miren Ettcheto, Ana López-Machado, Marta Espina, Eliana B Souto, Ruth Galindo, Antonio Camins, Maria Luisa García & Patric Turowski. (2020) Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases. Nanomedicine 15:12, pages 1239-1261.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.